Small cell lung cancer

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer.

An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England.

A new study in mice suggests that a type of lung cancer could be split into two different diseases based on cells’ molecular fingerprints.

A blood test could predict how well small-cell lung cancer (SCLC) patients will respond to treatment, according to new research published in Nature Medicine.

Having radiotherapy once a day for six and a half weeks or twice a day for three weeks – with chemotherapy – is equally good at treating small cell lung cancer.

A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer.